Clinical applications of PET in oncology.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Radiology

• Publication date

  2004-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1148/RADIOL.2312021185PMID 15044750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metastasis of primary melanoma to two separate lymph node basins: Prognostic significance

  2006cited by this paper
• Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy.

  2003cited by this paper
• Design considerations for PET scanners.

  2002cited by this paper
• Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET

  2002cited by this paper
• Combined image interpretation of computed tomography and hybrid PET in head and neck cancer

  2002cited by this paper
• Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms

  2002cited by this paper
• T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET.

  2002cited by this paper
• The Role of F-18 FDG Positron Emission Tomography in Preoperative Assessment of the Liver in Patients Being Considered for Curative Resection of Hepatic Metastases from Colorectal Cancer

  2002cited by this paper
• Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).

  2002cited by this paper
• Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients.

  2002cited by this paper
• 11C-acetate PET imaging of prostate cancer.

  2002cited by this paper
• The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study.

  2002cited by this paper
• Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma

  2002cited by this paper
• Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.

  2002cited by this paper
• Comparison of fluorine‐18 fluorodeoxyglucose positron emission tomography and Ga‐67 scintigraphy in evaluation of lymphoma

  2002cited by this paper
• Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

  2001cited by this paper
• Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography.

  2001cited by this paper
• Performance of a whole-body PET scanner using curve-plate NaI(Tl) detectors.

  2001cited by this paper
• Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods

  2001cited by this paper
• Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma.

  2001cited by this paper
• Systematic review of the diagnostic accuracy of 18F‐fluorodeoxyglucose positron emission tomography in melanoma patients

  2001cited by this paper
• Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL).

  2001cited by this paper
• Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer

  2001cited by this paper
• Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer.

  2001cited by this paper
• Analysis of mammography trials renews debate on mortality reduction.

  2001cited by this paper
• Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas.

  2001cited by this paper
• Value of 18-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients With Cystic Tumors of the Pancreas

  2001cited by this paper
• Cervical lymph node sarcoidosis as a pitfall in F-18 FDG positron emission tomography.

  2001cited by this paper
• Survival of Patients Evaluated by FDG-PET Before Hepatic Resection for Metastatic Colorectal Carcinoma: A Prospective Database Study

  2001cited by this paper
• Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions.

  2001cited by this paper
• Evaluation of Recurrent Squamous Cell Carcinoma of the Head and Neck with FDG Positron Emission Tomography

  2001cited by this paper
• Proposal of Standardization on Screening Tests for Detection of Distant Metastases from Head and Neck Cancer

  2001cited by this paper
• Incidental Thyroid Carcinoma Identified by Positron Emission Tomography Scanning Obtained for Metastatic Evaluation

  2001cited by this paper
• Comparison of intraoperative frozen section analysis of sentinel node with preoperative positron emission tomography in the diagnosis of axillary lymph node status in breast cancer patients.

  2001cited by this paper
• Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis.

  2001cited by this paper
• Pitfalls in imaging Hodgkin's disease with computed tomography and positron emission tomography using fluorine-18-fluorodeoxyglucose.

  2001cited by this paper
• Preoperative Diagnostic Value of [18F] Fluorodeoxyglucose Positron Emission Tomography in Patients With Radioiodine-Negative Recurrent Well-Differentiated Thyroid Carcinoma

  2001cited by this paper
• 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.

  2001cited by this paper
• Positron emission tomography 11C‐methionine and survival in patients with low‐grade gliomas

  2001cited by this paper
• F‐18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma

  2001cited by this paper
• Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.

  2001cited by this paper
• [18F]-FDG positron imaging in clinical management of lymphoma patients.

  2001cited by this paper
• Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer.

  2001cited by this paper
• Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography

  2001cited by this paper
• PET and PLAP in suspected testicular cancer relapse: beware sarcoidosis.

  2001cited by this paper
• Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma

  2001cited by this paper
• Incidental Focal Thyroid Uptake on FDG Positron Emission Tomographic Scans May Represent a Second Primary Tumor

  2001cited by this paper
• Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer

  2001cited by this paper
• Advances in the Staging of Intrathoracic Malignancies

  2001cited by this paper
• Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities: a retrospective review.

  2001cited by this paper
• FDG–PET sensitivity for melanoma lymph node metastases is dependent on tumor volume

  2001cited by this paper
• Differentiating benign and malignant pulmonary lesions with FDG-PET.

  2001cited by this paper
• Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results

  2001cited by this paper
• Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical note.

  2000cited by this paper
• Whole-Body FDG Positron Emission Tomographic Imaging for Staging Esophageal Cancer: Comparison with Computed Tomography

  2000cited by this paper
• Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.

  2000cited by this paper
• Scintillation crystals for PET.

  2000cited by this paper
• [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer.

  2000cited by this paper
• FDG PET of pleural effusions in patients with non-small cell lung cancer.

  2000cited by this paper
• Histopathologic Validation of Lymph Node Staging With FDG-PET Scan in Cancer of the Esophagus and Gastroesophageal Junction: A Prospective Study Based on Primary Surgery With Extensive Lymphadenectomy

  2000cited by this paper
• A review of the literature for whole-body FDG PET in the management of patients with melanoma.

  2000cited by this paper
• Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

  2000cited by this paper
• Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions.

  2000cited by this paper
• Elevated uptake of F-18 FDG in PET scans in nonmalignant disease.

  2000cited by this paper
• Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings.

  2000cited by this paper
• Clinical staging of esophageal carcinoma. CT, EUS, and PET.

  2000cited by this paper
• Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients

  2000cited by this paper
• PET imaging of musculoskeletal tumours with fluorine-18 α-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET

  2000cited by this paper
• Positron Emission Tomography With Fluorodeoxyglucose for Suspected Head and Neck Tumor Recurrence in the Symptomatic Patient

  2000cited by this paper
• Surveillance for recurrent head and neck cancer using positron emission tomography.

  2000cited by this paper
• Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.

  2000cited by this paper
• The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.

  2000cited by this paper
• Positron emission tomography scanning in malignant melanoma

  2000cited by this paper
• Positron emission tomography scanning in malignant melanoma.

  2000cited by this paper
• Contribution of Whole Body F-18-FDG-PET and Lymphoscintigraphy to the Assessment of Regional and Distant Metastases in Cutaneous Malignant Melanoma

  2000cited by this paper
• A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.

  2000cited by this paper
• Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences

  2000cited by this paper
• Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity.

  1999cited by this paper
• Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?--Results of a study in 50 patients.

  1999cited by this paper
• Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging.

  1999cited by this paper
• [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.

  1999cited by this paper
• CT and PET lung image registration and fusion in radiotherapy treatment planning using the chamfer-matching method.

  1999cited by this paper
• Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.

  1999cited by this paper
• Positron emission tomographic assessment of ”metabolic flare” to predict response of metastatic breast cancer to antiestrogen therapy

  1999cited by this paper
• FDG-PET in Esophageal Cancer. Incremental Value over Computed Tomography.

  1999cited by this paper
• Evaluation of FDG PET in patients with cervical cancer.

  1999cited by this paper
• Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.

  1999cited by this paper
• Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.

  1999cited by this paper
• Evaluation of the malignancy of glioma using 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining

  1999cited by this paper
• Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma

  1999cited by this paper
• Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.

  1999cited by this paper
• Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results.

  1999cited by this paper
• Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type.

  1999cited by this paper
• Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects.

  1999cited by this paper
• FDG positron emission tomography in head and neck cancer: pitfall or pathology?

  1999cited by this paper
• FDG and L-[1-11C]-tyrosine imaging of soft-tissue tumors before and after therapy.

  1999cited by this paper
• Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.

  1999cited by this paper
• Predictive factors of nodal metastases in oral cavity and oropharynx carcinomas

  1999cited by this paper
• Gallium-67 Scintigraphy in the Management: Hodgkin's Disease and Non-Hodgkin's Lymphoma

  1999cited by this paper
• Positron emission tomography in breast cancer: a clinicopathological correlation of results.

  1999cited by this paper

• GR-Diffusion: 3D Gaussian Representation Meets Diffusion in Whole-Body PET Reconstruction

  2026cites this paper
• From morphology to single-cell molecules: high-resolution 3D histology in biomedicine

  2025cites this paper
• Development of a Prototype AWSM-PET Device for Augmented Whole-Body PET Imaging and Initial Human Study

  2025cites this paper
• Evaluating long-term performance and quality control of the uMI 550 positron emission tomography- computed tomography (PET-CT) system: A comprehensive scientific analysis.

  2025cites this paper
• ANTIMATTER: THE POTENTIAL IMPACT ON THE FUTURE OF MEDICAL AND PHARMACEUTICAL INDUSTRIES

  2025cites this paper
• Generative super-resolution PET imaging with Fourier diffusion models

  2025cites this paper
• Brain metabolic vulnerability in 18-F FDG PET/CT predict future depression risk in young cancer survivors

  2025cites this paper
• FastDIP: An effective approach for accelerating unsupervised low-count PET image reconstruction

  2025cites this paper
• Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases - A Case-Based Radiosurgery Society Practice Guide and Review.

  2025cites this paper
• Investigation of optimal settings for deviceless respiratory synchronization in PET/CT examinations: effects of different reconstructions on image quality

  2025cites this paper
• Challenges in Differentiating Uterine Mesenchymal Tumors—Key Diagnostic Criteria

  2025cites this paper
• Cycle-constrained adversarial denoising convolutional network for PET image denoising: Multi-dimensional validation on large datasets with reader study and real low-dose data

  2025cites this paper
• FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview.

  2025cites this paper
• Host-guest supramolecular approach for the preparation of a 19F MRI-guided theranostic agent with long T2 relaxation times and its synergetic performances.

  2025cites this paper
• Boosting positron emission tomography reconstruction with positional encoding-based deep image prior.

  2025cites this paper
• Crystal-level timing calibration using cascaded photons of 60Co point source for long axial animal PET system

  2025cites this paper
• Physics-Constrained Diffusion Reconstruction with Posterior Correction for Quantitative and Fast PET Imaging

  2025cites this paper
• Fed-NDIF: A Noise-Embedded Federated Diffusion Model For Low-Count Whole-Body PET Denoising

  2025cites this paper
• Experimental Study of a Large Area High PDE SiPM in 0.11-μm CMOS Process for PET Applications

  2025cites this paper
• A DIY Bioreactor for in Situ Metabolic Tracking in 3D Cell Models via Hyperpolarized 13C NMR Spectroscopy

  2025cites this paper
• Expanding tracer space for positron emission tomography with high molar activity 18F-labeled α,α-difluoromethylalkanes

  2025cites this paper
• Gliomaların Tanısı ve Pozitron Emisyon Tomografisi (PET) İzleyicilerin (Tracer'larının) Güncel Kullanımı

  2025cites this paper
• Longitudinal FDG-PET Radiomics for Early Prediction of Treatment Response to Chemoradiation in Locally Advanced Cervical Cancer: A Pilot Study

  2024cites this paper
• PET/CT for the Opportunistic Screening of Osteoporosis and Fractures in Cancer Patients

  2024cites this paper
• Nuclear medicine imaging modalities to detect incidentalomas and their impact on patient management: a systematic review

  2024cites this paper
• Dosimetric and biological impact of activity extravasation of radiopharmaceuticals in PET imaging.

  2024cites this paper
• Role of Total Body PET/CT in Inflammatory Disorders

  2024cites this paper
• Cycle-Constrained Adversarial Denoising Convolutional Network for PET Image Denoising: Multi-Dimensional Validation on Large Datasets with Reader Study and Real Low-Dose Data

  2024cites this paper
• Assessing 18F-FDG PET/CT Uptake and its Correlation with Molecular Biomarkers in Penile Cancer

  2024cites this paper
• Usefulness of a new anthropomorphic phantom simulating the chest and abdomen regions in PET tests

  2024cites this paper
• From code sharing to sharing of implementations: Advancing reproducible AI development for medical imaging through federated testing.

  2024cites this paper
• Unexpected focal fluorodeoxyglucose uptake in main organs; pass through or pass by?

  2024cites this paper
• Population-based deep image prior for dynamic PET denoising: A data-driven approach to improve parametric quantification

  2024cites this paper
• Metabolic Responses of Lung Adenocarcinoma Cells to Survive under Stressful Conditions Associated with Tumor Microenvironment

  2024cites this paper
• PETformer network enables ultra-low-dose total-body PET imaging without structural prior

  2024cites this paper
• An evaluation of the physiological uptake range of 18F-fluoro-2-deoxy-D-glucose in normal ovaries of seven dogs using positron emission tomography/computed tomography

  2024cites this paper
• Imaging Techniques and Biochemical Biomarkers: New Insights into Diagnosis of Pancreatic Cancer

  2024cites this paper
• Artificial intelligence performance in detecting lymphoma from medical imaging: a systematic review and meta-analysis

  2024cites this paper
• Compact FPGA-Based Data Acquisition System for a High-Channel, High-Count-Rate TOF-PET Insert for Brain PET/MRI

  2024cites this paper
• Focal incidental colorectal fluorodeoxyglucose uptake: Should it be spotlighted?

  2024cites this paper
• PET Image Reconstruction Based on Graph Learning

  2024cites this paper
• GIÁ TRỊ CỦA PET/CT TRONG CHẨN ĐOÁN TỔN THƯƠNG NGUYÊN PHÁT Ở BỆNH NHÂN CARCINOMA DI CĂN HẠCH CỔ CHƯA RÕ NGUYÊN PHÁT

  2024cites this paper
• High-contrast Compton camera: Challenges to high-quality and broadband imaging

  2024cites this paper
• Simulation Design of a Triple Antenna Combination for PET‐MRI Imaging Compatible With 3, 7, and 11.74 T MRI Scanner

  2024cites this paper
• Dose-aware Diffusion Model for 3D PET Image Denoising: Multi-institutional Validation with Reader Study and Real Low-dose Data

  2024cites this paper
• The Clinical Significance of Incidental GIT Uptake on PET/CT: Radiologic, Endoscopic, and Pathologic Correlation

  2023cites this paper
• Unified Noise-Aware Network for Low-Count PET Denoising With Varying Count Levels

  2023cites this paper
• Brain glucose metabolism on [18F]-FDG PET/CT: a dynamic biomarker predicting depression and anxiety in cancer patients

  2023cites this paper
• Use of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography/computed tomography for staging thyroid carcinoma in a cat

  2023cites this paper
• The Diagnostic Value of [18F] FDG PET/CT Scan in Characterizing Adrenal Tumors.

  2023cites this paper
• Of rats and rocks: using pre-clinical PET imaging facilities in core analysis

  2023cites this paper
• Preoperative Hilar and Mediastinal Lymph Node Staging in Patients with Suspected or Diagnosed Lung Cancer: Accuracy of 18F-FDG-PET/CT:A Retrospective Cohort Study of 138 Patients

  2023cites this paper
• Reactive Palladium–Ligand Complexes for 11C-Carbonylation at Ambient Pressure: A Breakthrough in Carbon-11 Chemistry

  2023cites this paper
• Optimal clinical protocols for total-body 18F-FDG PET/CT examination under different activity administration plans

  2023cites this paper
• Artificial Intelligence–Driven Single-Shot PET Image Artifact Detection and Disentanglement

  2023cites this paper
• Zinc-Mediated Radiosynthesis of Unprotected Fluorine-18 Labelled α-Tertiary Amides.

  2023cites this paper
• Clinico-biological-radiomics (CBR) based machine learning for improving the diagnostic accuracy of FDG-PET false-positive lymph nodes in lung cancer

  2023cites this paper
• Distinct FDG PET/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational study

  2023cites this paper
• PET Tracer Conversion among Brain PET via Variable Augmented Invertible Network

  2023cites this paper
• Tumor Progression from a Fibroblast Activation Protein Perspective: Novel Diagnostic and Therapeutic Scenarios for Colorectal Cancer

  2023cites this paper
• DDPET-3D: Dose-aware Diffusion Model for 3D Ultra Low-dose PET Imaging

  2023cites this paper
• A Two-Branch Neural Network for Short-Axis PET Image Quality Enhancement

  2023cites this paper
• Neurosarcoidosis With Multi-Organ Involvement: A Case Report and Literature Review

  2023cites this paper
• Correlation analysis of positron emission tomography/computed tomography-magnetic resonance imaging of cannabinoid type 1 receptor in the lumbar spine and brain of aged osteoporosis female cynomolgus monkeys

  2023cites this paper
• Multi-institutional PET/CT image segmentation using federated deep transformer learning

  2023cites this paper
• New standards for phantom image quality and SUV harmonization range for multicenter oncology PET studies

  2022cites this paper
• Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond

  2022cites this paper
• Role of PET-CT (Positron Emission Tomography-Computed Tomography) in Cancer Evaluation and Treatment

  2022cites this paper
• Diagnostic and prognostic value of F-18 FDG PET/CT in patients with carcinoma of unknown primary

  2022cites this paper
• 18F‐fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma

  2022cites this paper
• PET imaging in breast cancer

  2022cites this paper
• Virtual high-count PET image generation using a deep-learning method.

  2022cites this paper
• A personalized deep learning denoising strategy for low-count PET images

  2022cites this paper
• Hepatic superscan on fluorine-18 fluorodeoxyglucose PET/computed tomography imaging: a specific manifestation for diagnosing lymphoma or leukemia involvement

  2022cites this paper
• Enhanced direct joint attenuation and scatter correction of whole-body PET images via context-aware deep networks

  2022cites this paper
• 18F-Fluorodeoxyglucose positron emission/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: What do we know?

  2022cites this paper
• Carbon-11 patents (2012–2022): synthetic methodologies and novel radiotracers for PET imaging

  2022cites this paper
• Image denoising in the deep learning era

  2022cites this paper
• A Review of Spectroscopic and Non-Spectroscopic Techniques for Diagnosing Breast Cancer.

  2022cites this paper
• Metabolic Impact of Immune-Suppressor Cells in Cancer Patients

  2022cites this paper
• Histogram analysis of 18F-FDG PET imaging SUVs may predict the histologic grade of oral squamous cell carcinoma.

  2022cites this paper
• Diagnostic accuracy and clinical impact of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in Positron Emission Tomography - Computed Tomography (PET-CT)-positive mediastinal lymphadenopathies in subjects with thoracic or extra-thoracic malignancy.

  2022cites this paper
• Role of 18F-FDG PET/CT in management of adrenocortical carcinoma: a comprehensive review of the literature

  2022cites this paper
• Estimation of the Internal Dose Imparted by 18F-Fluorodeoxyglucose to Tissues by Using Fricke Dosimetry in a Phantom and Positron Emission Tomography

  2022cites this paper
• Positron Emission Tomography Molecular Imaging for Phenotyping and Management of Lymphoma

  2022cites this paper
• Current advances in the application of nanomedicine in bladder cancer.

  2022cites this paper
• Heterodimeric RGD-NGR PET Tracer for the Early Detection of Pancreatic Cancer

  2022cites this paper
• Non-radioactive elements for prompt gamma enhancement in proton therapy

  2022cites this paper
• Application of nanotechnology in the diagnosis and treatment of bladder cancer

  2021cites this paper
• New PET radiopharmaceuticals for cancer imaging

  2021cites this paper
• 두경부암의 종격동 림프절 전이: 예측인자 및 영상 소견

  2021cites this paper
• Clinically significant findings in patients with focal incidental colorectal abnormalities on positron emission tomography‐CT scans

  2021cites this paper
• Dosimetry in positron emission tomography

  2021cites this paper
• Mediastinal Lymph Node Metastasis from Head and Neck Cancer: Predictive Factors and Imaging Features.

  2021cites this paper
• Mediastinal Lymph Node Metastasis from Head and Neck Cancer: Predictive Factors and Imaging Features

  2021cites this paper
• Clinical practice (Graz, Austria and Gießen, Germany)

  2021cites this paper
• Correlation of 4′-[methyl-11C]-thiothymidine PET with Ki-67 immunohistochemistry separately in patients with newly diagnosed and recurrent gliomas

  2021cites this paper
• Emerging methods for prostate cancer imaging: evaluating cancer structure and metabolic alterations more clearly

  2021cites this paper
• Hypermetabolic pulmonary lesions on FDG-PET/CT: tularemia or neoplasia?

  2021cites this paper
• Optimization of subharmonic generation from ultrasound contrast agents at high frequency ultrasound

  2021cites this paper